Superbrandz Medical Innovations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 56.23%
(FY 2022)
- Ebitda 98.77%
(FY 2022)
- Net Worth -1.08%
(FY 2022)
- Total Assets -0.58%
(FY 2022)
About Superbrandz Medical Innovations
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tanpreet Marwah and Kishore Shah serve as directors at the Company.
- CIN/LLPIN
U24304MH2017PTC297763
- Company No.
297763
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Superbrandz Medical Innovations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanpreet Marwah  | Director | 02-Mar-2019 | Current |
| Kishore Shah | Director | 04-Mar-2019 | Current |
Financial Performance of Superbrandz Medical Innovations.
Superbrandz Medical Innovations Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 56.23% increase in profit. The company's net worth dipped by a decrease of 1.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Superbrandz Medical Innovations?
Unlock access to Superbrandz Medical Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ideal Processing House (Textiles) Private LimitedActive 45 years 8 months
Tanpreet Marwah is a mutual person
- Uppal Health Resorts & Spa Private LimitedActive 24 years 10 months
Tanpreet Marwah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Superbrandz Medical Innovations?
Unlock and access historical data on people associated with Superbrandz Medical Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Superbrandz Medical Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Superbrandz Medical Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
